vs
Side-by-side financial comparison of LANDMARK BANCORP INC (LARK) and Verastem, Inc. (VSTM). Click either name above to swap in a different company.
LANDMARK BANCORP INC is the larger business by last-quarter revenue ($18.8M vs $11.2M, roughly 1.7× Verastem, Inc.). LANDMARK BANCORP INC runs the higher net margin — 27.0% vs -876.3%, a 903.3% gap on every dollar of revenue.
Landmark Bancorp Inc is a U.S.-based bank holding company operating Landmark National Bank, primarily serving communities across Kansas. It provides a full range of personal and commercial banking services including deposit accounts, residential mortgages, commercial loans, and wealth management solutions, catering to individual consumers, small businesses and local mid-sized enterprises.
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
LARK vs VSTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.8M | $11.2M |
| Net Profit | $5.1M | $-98.5M |
| Gross Margin | — | — |
| Operating Margin | — | -362.2% |
| Net Margin | 27.0% | -876.3% |
| Revenue YoY | 14.0% | — |
| Net Profit YoY | 7.8% | -311.1% |
| EPS (diluted) | — | $-1.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $18.8M | — | ||
| Q4 25 | $18.7M | — | ||
| Q3 25 | $18.2M | $11.2M | ||
| Q2 25 | $17.3M | $2.1M | ||
| Q1 25 | $16.5M | — | ||
| Q4 24 | $15.8M | — | ||
| Q3 24 | $15.9M | $0 | ||
| Q2 24 | $14.7M | $10.0M |
| Q1 26 | $5.1M | — | ||
| Q4 25 | $4.7M | — | ||
| Q3 25 | $4.9M | $-98.5M | ||
| Q2 25 | $4.4M | $-25.9M | ||
| Q1 25 | $4.7M | — | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $3.9M | $-24.0M | ||
| Q2 24 | $3.0M | $-8.3M |
| Q1 26 | — | — | ||
| Q4 25 | 31.7% | — | ||
| Q3 25 | 33.4% | -362.2% | ||
| Q2 25 | 30.9% | -2047.9% | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 24.5% | -182.8% |
| Q1 26 | 27.0% | — | ||
| Q4 25 | 32.1% | — | ||
| Q3 25 | 27.1% | -876.3% | ||
| Q2 25 | 25.4% | -1213.6% | ||
| Q1 25 | 28.5% | — | ||
| Q4 24 | 26.5% | — | ||
| Q3 24 | 24.8% | — | ||
| Q2 24 | 20.5% | -82.6% |
| Q1 26 | — | — | ||
| Q4 25 | $0.66 | — | ||
| Q3 25 | $0.85 | $-1.35 | ||
| Q2 25 | $0.75 | $-0.62 | ||
| Q1 25 | $0.81 | — | ||
| Q4 24 | $0.47 | — | ||
| Q3 24 | $0.68 | $-0.60 | ||
| Q2 24 | $0.52 | $-0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.9M | $137.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-15.5M |
| Total Assets | $1.6B | $176.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $31.9M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $137.7M | ||
| Q2 25 | — | $164.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $113.2M | ||
| Q2 24 | — | $83.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $40.5M | ||
| Q2 24 | — | $40.3M |
| Q1 26 | — | — | ||
| Q4 25 | $160.6M | — | ||
| Q3 25 | $155.7M | $-15.5M | ||
| Q2 25 | $148.4M | $36.1M | ||
| Q1 25 | $142.7M | — | ||
| Q4 24 | $136.2M | — | ||
| Q3 24 | $139.7M | $11.1M | ||
| Q2 24 | $128.3M | $18.9M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | $176.9M | ||
| Q2 25 | $1.6B | $196.3M | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | $126.4M | ||
| Q2 24 | $1.6B | $105.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.66× | ||
| Q2 24 | — | 2.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-36.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $21.6M | — | ||
| Q3 25 | $10.3M | $-36.2M | ||
| Q2 25 | $439.0K | $-32.7M | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $8.1M | $-23.8M | ||
| Q2 24 | $4.4M | $-27.6M |
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | — | ||
| Q3 25 | $10.1M | — | ||
| Q2 25 | $354.0K | — | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $11.9M | — | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $3.8M | $-27.6M |
| Q1 26 | — | — | ||
| Q4 25 | 112.5% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 75.6% | — | ||
| Q3 24 | 49.3% | — | ||
| Q2 24 | 25.6% | -275.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 4.2% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.56× | — | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 4.34× | — | ||
| Q3 24 | 2.06× | — | ||
| Q2 24 | 1.45× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
